MC
MDB Capital Group
OtherQuietMDB Capital Group is an IP-driven public venture bank launching disruptive technologies into the public markets.
4
Investments
3
Exits
—
AUM
75.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for MDB Capital Group.
Investment Thesis & Strategy
MDB Capital Group invests in various stages of fintech and impact investing companies with disruptive technologies, focusing on those with strong intellectual property and a path to the public markets.
Investment Activity
Deals per year over the last 7 years
1
20124
20130
20142
20150
20163
20171
2018Portfolio Companies
Selected investments from their portfolio of 4 companies
T
Turning Point Therapeutics
Biotech · Growth, 2018
K
Krystal Biotech
Biotech · Growth, 2017
A
Aprea Therapeutics
Biotech · Growth, 2017
B
Biohaven Pharmaceutical
Biotech · Growth, 2017
A
Aeglea BioTherapeutics
Biotech · Growth, 2015
R
Rhythm Pharmaceuticals
Biotech · Growth, 2015
C
CytomX Therapeutics
Biotech · Growth, 2013
P
Protagonist Therapeutics
Biotech · Growth, 2013
C
Cara Therapeutics
Biotech · Growth, 2013
F
Fate Therapeutics
Biotech · Growth, 2013
M
Mirati Therapeutics
Biotech · Growth, 2012
Frequently Asked Questions
MDB Capital Group invests across multiple stages. Sign up to view detailed stage data.
Related Investors
Comerica Incorporated
Dallas, United States · 77 deals
Park Cities Asset Management
Dallas, United States · 6 deals
White Rock Capital
Dallas, United States · 5 deals
Texas Capital Bank
Dallas, United States · 4 deals
ORIX USA Corporation
Dallas, United States · 4 deals
SRB Management
Dallas, United States · 3 deals